The first Brooklyn ImmunoTherapeutics trade was made in Q1 2021. Since then Jim Simons bought shares four more times and sold shares on two occasions. The investor sold all their shares in Q4 2022 and doesn't own any shares in Brooklyn ImmunoTherapeutics anymore.